Aceneuramic acid
MUSCULO-SKELETAL SYSTEM
Also known as: N-acetylneuraminic acid, Neu5Ac
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Aceneuramic acid is a drug catalogued in DrugCentral. It was first approved by the PMDA in 2024. Recorded indications include Suppression of the progression of muscular weakness in distal myopathy.
- Indications: Suppression of the progression of muscular weakness in distal myopathy.
- ATC code: M09AX05 (Other drugs for disorders of the musculo-skeletal system).
- Molecular formula: C11H19NO9; molecular weight 309.27 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Suppression of the progression of muscular weakness in distal myopathy
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 2024-03-26 | PMDA | — | Nobelpharma Co., Ltd. | Yes |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
M09AX05 | MUSCULO-SKELETAL SYSTEM › OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM › OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM › Other drugs for disorders of the musculo-skeletal system |
Chemical structure
| Molecular formula | C11H19NO9 |
|---|---|
| Molecular weight | 309.27 g/mol |
| CAS number | — |
| InChIKey | KBGAYAKRZNYFFG-BOHATCBPSA-N |
| PubChem CID | 445063 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Aceneuramic acid used for?
DrugCentral lists the following indications for Aceneuramic acid: Suppression of the progression of muscular weakness in distal myopathy.
When was Aceneuramic acid first approved?
Aceneuramic acid was first approved by the PMDA in 2024.
What is the chemical formula of Aceneuramic acid?
Aceneuramic acid has the molecular formula C11H19NO9 and a molecular weight of 309.27 g/mol.
Browse: all drugs starting with A · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 5864 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL152452 — compound record and bioactivity
- PubChem CID 445063 — chemical identifiers
- DrugBank DB11797 — drug record
- FDA UNII GZP2782OP0 — substance identity
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.